RWC Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,565
Closed -$227K 145
2016
Q4
$227K Sell
2,565
-885
-26% -$80.5K 0.01% 137
2016
Q3
$333K Hold
3,450
0.02% 143
2016
Q2
$296K Buy
+3,450
New +$310K 0.02% 136

Other funds holding IBB

RWC Asset Management's IBB Position: Q1 2017 in Review

RWC Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2017, closing a stake of 2,565 shares — an estimated $227K sold.

RWC Asset Management first reported a position in IBB in Q2 2016 and held it in 3 quarters. The position peaked at $333K in Q3 2016. 520 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

  • RWC Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2017 after selling out during the quarter.
  • RWC Asset Management sold 2,565 iShares Biotechnology ETF shares in Q1 2017, an estimated $227K.
  • RWC Asset Management first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 3 quarters.
  • RWC Asset Management's iShares Biotechnology ETF position peaked at $333K in Q3 2016.
  • 520 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on RWC Asset Management's 13F filing for Q1 2017, filed 9 May 2017.